ICCM | IceCure Medical Ltd Stock Overview

(Stock Exchange: NASDAQ)

Day's Range	0.5910 - 0.7564
52 Week Range	0.4800 - 1.5700
Beta	N/A
Implied Volatility	N/A
IV Rank	N/A
Day's Volume	1,663,408
Average Volume	620,529
Shares Outstanding	49,517,660
Market Cap	35,266,477
Sector	Healthcare
Industry	Medical - Devices
IPO Date	2021-08-26

Valuation
Profitability
Growth
Health
P/E Ratio	-2.46
Forward P/E Ratio	N/A
EPS	-0.29
1YR Price Target	N/A
Dividend Yield	N/A
Dividend Per Share	N/A
Dividend ExDate	N/A
Dividend PayDate	N/A
Employees	71
Country	Israel
Website	ICCM

IceCure Medical Ltd, a medical device company, engages in the research, development, and commercialization of medical devices for cryoablation (freezing) of tumors in the human body. It offers ProSense system, a cryoablation solution for the treatment of breast tumors. The company was incorporated in 2006 and is headquartered in Caesarea, Israel.

ICCM's peers: BRSYF, OSA, SRDX, SSKN, TNON, BWAY, PETV, SINT, CTSO, NPCE, CLPT, TELA, KIDS, CNMD, ITGR, SGHT, TMCI, ESTA

*Chart delayed

Analyzing fundamentals for ICCM we got that it has weak fundamentals where Valuation is considered to be significantly overvalued, Profitability is unacceptably poor, Growth is bad and Health is weak. For more detailed analysis please see ICCM Fundamentals page.

Watching at ICCM technicals we can see that long-term trend is bearish, the same as bearish middle-term trend, as well as bearish short-term trend. More technicals details can be found on ICCM Technicals page.